Search & Analyze

Accent Microcell Ltd.

HealthcarePharmaceuticals & Drugs

www.accentmicrocell.comBSE: N/ANSE: ACCENTMIC

₹660.10NSE

₹660.10

₹1.58K Cr

36.11

5.75

18.65%

₹0.00

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,853.50	148.56	4,44,716.74	0.86	1,115.14	49.67%	5,741.13	2.61%	13.27
DIVI'S LAB. DIVISLAB	9,199.70	83.04	2,44,223.13	0.33	891.00	59.96%	2,974.00	26.18%	21.89
TORRENT PHAR TORNTPHARM	4,823.05	86.01	1,83,453.32	0.79	492.00	-10.71%	4,158.00	58.94%	19.77
ZYDUSLIFE ZYDUSLIFE	1,105.00	31.36	1,10,224.17	0.09	339.60	-11.72%	2,872.20	10.97%	16.05
CIPLA LTD. CIPLA	1,359.75	35.73	1,09,848.55	0.96	862.16	-33.84%	5,077.68	0.62%	14.04
LAURUSLABS LAURUSLABS	1,906.00	118.03	1,02,983.51	0.10	289.96	83.59%	1,757.16	22.64%	16.08
DR.REDDY'S DRREDDY	1,145.25	144.14	95,591.76	0.70	404.70	-86.33%	5,136.60	-34.23%	12.67
Accent Microcell Ltd. ACCENTMIC	660.10	36.11	1,583.52	0.15					24.88

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	165.71	197.27	245.50	264.58	349.03
	165.71	197.27	245.50	264.58	349.03
EXPENDITURE :
Increase/Decrease in Stock	-6.94	-9.71	14.62	-3.85	-3.55
Raw Material Consumed	120.28	129.19	131.11	165.35	219.64
Power & Fuel Cost	3.34	23.26	22.91	20.14	21.94
Employee Cost	7.62	8.97	13.30	15.49	18.21
Other Manufacturing Expenses	9.94	9.63	8.99	9.52	12.13
General and Administration Expenses	2.51	2.77	2.89	2.76	3.15
Selling and Distribution Expenses	15.55	13.78	9.93	11.74	18.16
Miscellaneous Expenses	0.43	0.45	2.27	1.52	2.66
	152.74	178.32	206.03	222.67	292.34
Operating Profit (Excl OI)	12.97	18.95	39.47	41.91	56.69
	1.83	2.49	3.63	6.41	6.77
	14.80	21.44	43.10	48.32	63.46
Interest	3.07	2.53	1.15	0.35	0.54
PBDT	11.74	18.91	41.96	47.97	62.92
	4.15	4.11	4.43	4.21	4.66
Profit Before Taxation & Exceptional Items	7.59	14.80	37.53	43.76	58.26
Exceptional Income / Expenses			-1.00
	7.59	14.80	36.53	43.76	58.26
Provision for Tax	1.70	2.57	6.36	10.70	14.40
	5.89	12.23	30.17	33.06	43.86
Extra items				0.00	0.00
Consolidated Net Profit	5.89	12.23	30.17	33.06	43.86
Profit Balance B/F	12.95	24.38	36.62	65.75	96.71
Appropriations	18.84	36.61	66.78	98.82	140.57
Equity Dividend %	8.00%	8.00%	10.00%	10.00%	10.00%
	4.57	9.45	14.34	15.71	18.28
Adjusted EPS	1.52	9.45	14.34	15.71	18.28

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	12.90	12.94	21.04	21.04	23.99
Total Reserves	19.19	37.48	142.79	173.75	251.50
Reserve excluding Revaluation Reserve	19.19	37.48	142.79	173.75	251.50
Revaluation reserve	0.00		0.00
	32.09	50.43	163.83	194.79	275.48
Secured Loans	3.24	2.48	1.47	0.86	0.34
Unsecured Loans	3.70	2.99	0.02
Deferred Tax Assets / Liabilities	1.24	0.89	0.86	0.89	-0.13
Long Term Provisions	0.42	0.23	0.79	1.44	2.34
Total Non-Current Liabilities	8.60	6.59	3.15	3.19	2.55
Trade Payables	30.10	34.58	19.23	18.48	19.71
Other Current Liabilities	8.96	4.14	7.72	10.79	19.80
Short Term Borrowings	14.43	14.63	9.91
Short Term Provisions	0.44	2.85	9.61	22.77	16.82
Total Current Liabilities	53.92	56.20	46.47	52.05	56.33
Total Liabilities	94.61	113.23	213.46	250.03	334.37
Gross Block	58.53	63.52	65.68	88.77	93.74
Less: Accumulated Depreciation	28.42	32.21	36.64	40.78	40.72
Net Block	30.12	31.31	29.04	47.99	53.01
Capital Work in Progress			1.86	12.77	101.80
Non Current Investments		0.00
Long Term Investment	0.00	0.00	0.00
Long Term Loans & Advances	0.57	1.71	10.50	13.22	11.35
Other Non Current Assets	0.00		0.00	0.04	0.46
Total Non-Current Assets	30.69	33.02	41.40	74.02	166.64
Inventories	39.59	41.94	32.98	33.63	32.41
Sundry Debtors	17.04	30.35	53.80	64.87	91.30
Cash and Bank	2.83	2.05	72.49	51.02	20.10
Other Current Assets	3.98	2.57	2.36	3.20	3.53
Short Term Loans and Advances	0.49	3.24	10.42	23.30	20.38
Total Current Assets	63.92	80.15	172.06	176.01	167.73
Net Current Assets (Including Current Investments)	10.00	23.95	125.58	123.96	111.40
Miscellaneous Expenses not written off		0.06
Total Assets	94.61	113.23	213.46	250.03	334.37
Contingent Liabilities			4.12	4.62	19.87
Total Debt	24.10	22.81	12.79	1.51	0.88
	24.87	38.92	77.86	92.57	114.84
Adjusted Book Value	8.29	38.92	77.86	92.57	114.84

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	7.59	14.80	36.53	43.76	58.26
Adjustment	6.75	6.27	5.97	0.73	4.42
Changes In working Capital	2.19	-10.80	-24.87	-8.51	-30.45
Cash Flow after changes in Working Capital	16.53	10.26	17.63	35.98	32.23
Cash Flow from Operating Activities	14.87	7.57	11.33	24.67	18.64
Cash Flow from Investing Activities	-4.30	-4.04	-82.34	-8.61	-48.88
Cash Flow from Financing Activitie	-9.67	-4.32	72.27	-13.70	35.75
Net Cash Inflow / Outflow	0.90	-0.79	1.26	2.37	5.51
Opening Cash & Cash Equivalents	0.20	1.10	0.31	1.58	3.94
Closing Cash & Cash Equivalent	1.10	0.31	1.58	3.94	9.45

Ratios

Valuation

36.11

5.75

24.65

4.54

18.28

114.84

Profitability

18.65

24.88

15.01

16.24

12.57

Leverage & Liquidity

0.00

2.98

108.87

Returns

0.15

1.19

Shareholding Pattern

Numbers in percentages

Particulars	Mar '24	Sep '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	55.09	55.09	55.09	55.09	55.44	55.44	55.47	53.02
	1.65	1.68	2.20	2.89	3.29	3.86	4.17	4.45
	43.26	43.23	42.70	42.01	41.27	40.70	40.36	42.53
	44.91	44.91	44.91	44.91	44.56	44.56	44.53	46.98
No. of Shareholders	2,418	2,999	2,834	2,982	3,061	3,076	3,054	3,178

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-07-06	AGM	Accent Microcell Limited has informed the Exchange regarding Outcome of Board Meeting held on July 06, 2026.
2026-05-12	Ex Dividend		2026-07-17	2026-07-17
2026-05-07	Board Meeting	Financial Results/Dividend/Other business matters

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Accent Microcell Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

10 members across the board and senior leadership

Vasant Vadilal Patel

Chairman

—

Ghanshyam Patel

Managing Director & Chief Financial Officer

—

Nitin Patel

Whole Time Director

—

Vinod Patel

Executive Director

—

Vinodbhai Patel

Whole Time Director

—

Chintan Bhatt

Non Executive Independent Director

—

Rajatkumar Dineshbhai Patel

Non Executive Independent Director

—

Shreya Shah

Non Executive Independent Director

—

Hiral Gediya

Company Secretary & Compliance Officer

—

Pooja Shah

Additional Director

—

ACCENTMIC Latest News

News

No news found for Accent Microcell Ltd..

ACCENTMIC

₹660.10

+0%